Billiontoone’s (BLLN) Buy Rating Reaffirmed at Guggenheim

Guggenheim restated their buy rating on shares of Billiontoone (NASDAQ:BLLN) in a report released on Thursday morning,Benzinga reports. Guggenheim currently has a $120.00 target price on the stock.

Other equities analysts have also recently issued research reports about the company. Stifel Nicolaus initiated coverage on Billiontoone in a research note on Monday, December 1st. They set a “buy” rating and a $145.00 target price on the stock. Wells Fargo & Company began coverage on shares of Billiontoone in a report on Monday, December 1st. They set an “equal weight” rating and a $110.00 price target for the company. Weiss Ratings assumed coverage on shares of Billiontoone in a research report on Tuesday, February 3rd. They set a “sell (d)” rating on the stock. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a research report on Tuesday, December 2nd. Finally, Jefferies Financial Group initiated coverage on shares of Billiontoone in a report on Monday, December 1st. They set a “hold” rating and a $117.00 price target on the stock. Six investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $129.57.

Billiontoone Trading Down 1.1%

NASDAQ:BLLN traded down $0.77 during trading hours on Thursday, hitting $71.40. 21,362 shares of the stock traded hands, compared to its average volume of 258,259. The business’s 50 day simple moving average is $85.87. The firm has a market capitalization of $3.27 billion and a price-to-earnings ratio of 714.00. Billiontoone has a fifty-two week low of $66.00 and a fifty-two week high of $138.70.

Billiontoone (NASDAQ:BLLN) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of $0.04 by $0.07. The business had revenue of $96.05 million for the quarter, compared to analysts’ expectations of $85.85 million. The company’s revenue for the quarter was up 113.0% compared to the same quarter last year.

Institutional Trading of Billiontoone

Large investors have recently added to or reduced their stakes in the business. Green Alpha Advisors LLC bought a new stake in Billiontoone in the fourth quarter worth $436,000. FNY Investment Advisers LLC acquired a new position in shares of Billiontoone during the 4th quarter worth about $497,000. Massachusetts Financial Services Co. MA acquired a new position in shares of Billiontoone during the 4th quarter worth about $13,373,000. Baillie Gifford & Co. bought a new stake in Billiontoone during the 4th quarter valued at approximately $103,786,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new stake in Billiontoone in the 4th quarter valued at approximately $1,348,000.

Key Headlines Impacting Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Reported stronger-than-expected Q4 results and raised 2026 revenue guidance — Q4 revenue $96.05M (vs. $85.85M est.), EPS $0.11 (vs. $0.04 est.), revenue +113% YoY; company boosted full‑year 2026 revenue guidance to $430M–$445M (well above the ~$356M consensus). This fundamental beat and guidance lift support upside. GlobeNewswire Release
• Positive Sentiment: Conference call and earnings coverage highlighted “record revenue growth” and strategic progress that investors often view as confirmation of the company’s growth trajectory. Yahoo Finance: Q4 Highlights
• Neutral Sentiment: BTIG lowered its price target from $160 to $140 but left a “buy” rating — the cut trims upside but keeps institutional support. StreetInsider: BTIG Note
• Neutral Sentiment: Short-interest reports in the data feed show anomalous/zero values (0 shares / NaN changes), so there’s no reliable evidence of a meaningful short-squeeze or large new short position influencing the move.
• Negative Sentiment: Wells Fargo cut its price target from $110 to $90 and moved to an “equal weight” rating — this downgrade increases near-term selling pressure and signals more cautious analyst sentiment. Benzinga: Wells Fargo Note
• Negative Sentiment: Valuation and technical context: BLLN carries a very high trailing P/E (~699) and its 50‑day moving average (~$85.87) sits above the current price — factors that can prompt profit‑taking and make the stock sensitive to analyst sentiment changes.
• Positive Sentiment: Guggenheim reaffirmed a “buy” and $120 target, providing an offsetting bullish institutional view. Benzinga: Guggenheim Note

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.